Flagship VentureLabs IV, LLC's Net Worth

$4.73 Billion

Estimate Recalculated Feb 23, 2024 04:08PM EST

Who is Flagship VentureLabs IV, LLC?

Flagship VentureLabs IV, LLC has an estimated net worth of $4.73 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., Seres Therapeutics, Inc., Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..

SEC CIK

Flagship VentureLabs IV, LLC's CIK is 0001642578

Past Insider Trading and Trends

2018 was Flagship VentureLabs IV, LLC's most active year for acquiring shares with 20 total transactions. Flagship VentureLabs IV, LLC's most active month to acquire stocks was the month of June. 2018 was Flagship VentureLabs IV, LLC's most active year for disposing of shares, totalling 24 transactions. Flagship VentureLabs IV, LLC's most active month to dispose stocks was the month of April. 2019 saw Flagship VentureLabs IV, LLC paying a total of $10,000,000.00 for 7,154,671 shares, this is the most they've acquired in one year. In 2016 Flagship VentureLabs IV, LLC cashed out on 17,758,490 shares for a total of $27,600,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Moderna, Inc. (MRNA) Snapshot price: $99.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
47.34M
47.34M
Dec 11
Form 3
0
0
No matching records found

Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+158.12%
1.12M
1.83M
Mar 4
Form 3
0
0
No matching records found

Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.025

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.02%
-2.00M
$27.60
-$27,600,000.00
14.64M
May 25
Form 3
0
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+185.29%
33.3M
51.27M
Jul 20
Form 3
0
0
No matching records found

Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $7.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-35.64%
-1.66M
2.99M
Aug 17
Form 4
+47.55%
4.59M
$12.50
$5,000,000.00
14.25M
Jul 6
Form 3
0
0
No matching records found